Literature DB >> 17676625

Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity.

Dan Li1, Kirill Gromov, Kjeld Søballe, J Edward Puzas, Regis J O'Keefe, Hani Awad, Hicham Drissi, Edward M Schwarz.   

Abstract

Although osteomyelitis (OM) remains a serious problem in orthopedics, progress has been limited by the absence of an in vivo model that can quantify the bacterial load, metabolic activity of the bacteria over time, immunity, and osteolysis. To overcome these obstacles, we developed a murine model of implant-associated OM in which a stainless steel pin is coated with Staphylococcus aureus and implanted transcortically through the tibial metaphysis. X-ray and micro-CT demonstrated concomitant osteolysis and reactive bone formation, which was evident by day 7. Histology confirmed all the hallmarks of implant-associated OM, namely: osteolysis, sequestrum formation, and involucrum of Gram-positive bacteria inside a biofilm within necrotic bone. Serology revealed that mice mount a protective humoral response that commences with an IgM response after 1 week, and converts to a specific IgG2b response against specific S. aureus proteins by day 11 postinfection. Real-time quantitative PCR (RTQ-PCR) for the S. aureus specific nuc gene determined that the peak bacterial load occurs 11 days postinfection. This coincidence of decreasing bacterial load with the generation of specific antibodies is suggestive of protective humoral immunity. Longitudinal in vivo bioluminescent imaging (BLI) of luxA-E transformed S. aureus (Xen29) combined with nuc RTQ-PCR demonstrated the exponential growth phase of the bacteria immediately following infection that peaks on day 4, and is followed by the biofilm growth phase at a significantly lower metabolic rate (p < 0.05). Collectively, these studies demonstrate the first quantitative model of implant-associated OM that defines the kinetics of microbial growth, osteolysis, and humoral immunity following infection. (c) 2007 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17676625      PMCID: PMC2701346          DOI: 10.1002/jor.20452

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  27 in total

Review 1.  Advances in in vivo bioluminescence imaging of gene expression.

Authors:  Christopher H Contag; Michael H Bachmann
Journal:  Annu Rev Biomed Eng       Date:  2002-03-22       Impact factor: 9.590

Review 2.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

3.  Collagen and fibronectin binding in experimental staphylococcal osteomyelitis.

Authors:  A Johansson; J I Flock; O Svensson
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

4.  Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis.

Authors:  M O Elasri; J R Thomas; R A Skinner; J S Blevins; K E Beenken; C L Nelson; M S Smeltzer
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

5.  Comparison of different approaches to quantify Staphylococcus aureus cells by real-time quantitative PCR and application of this technique for examination of cheese.

Authors:  I Hein; A Lehner; P Rieck; K Klein; E Brandl; M Wagner
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

6.  Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct.

Authors:  K P Francis; D Joh; C Bellinger-Kawahara; M J Hawkinson; T F Purchio; P R Contag
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.

Authors:  Xinping Zhang; Edward M Schwarz; Donald A Young; J Edward Puzas; Randy N Rosier; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 8.  Osteomyelitis.

Authors:  Daniel P Lew; Francis A Waldvogel
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

9.  Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue.

Authors:  Ian Marriott; David L Gray; Susanne L Tranguch; Vance G Fowler; Martin Stryjewski; L Scott Levin; Michael C Hudson; Kenneth L Bost
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

10.  A new model of implant-related osteomyelitis in rats.

Authors:  M Lucke; G Schmidmaier; S Sadoni; B Wildemann; R Schiller; A Stemberger; N P Haas; M Raschke
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2003-10-15       Impact factor: 3.368

View more
  67 in total

1.  Murine immune response to a chronic Staphylococcus aureus biofilm infection.

Authors:  Ranjani Prabhakara; Janette M Harro; Jeff G Leid; Megan Harris; Mark E Shirtliff
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

Review 2.  Infected animal models for tissue engineering.

Authors:  Alexander M Tatara; Sarita R Shah; Carissa E Livingston; Antonios G Mikos
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

3.  Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin.

Authors:  Sana S Dastgheyb; Sommer Hammoud; Constantinos Ketonis; Andrew Yongkun Liu; Keith Fitzgerald; Javad Parvizi; James Purtill; Michael Ciccotti; Irving M Shapiro; Michael Otto; Noreen J Hickok
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

4.  Designer Dual Therapy Nanolayered Implant Coatings Eradicate Biofilms and Accelerate Bone Tissue Repair.

Authors:  Jouha Min; Ki Young Choi; Erik C Dreaden; Robert F Padera; Richard D Braatz; Myron Spector; Paula T Hammond
Journal:  ACS Nano       Date:  2016-03-02       Impact factor: 15.881

5.  Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus.

Authors:  Ranjani Prabhakara; Janette M Harro; Jeff G Leid; Achsah D Keegan; Megan L Prior; Mark E Shirtliff
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

6.  Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.

Authors:  Daniel P Crane; Kirill Gromov; Dan Li; Kjeld Søballe; Christian Wahnes; Hubert Büchner; Matthew J Hilton; Regis J O'Keefe; Clinton K Murray; Edward M Schwarz
Journal:  J Orthop Res       Date:  2009-08       Impact factor: 3.494

7.  Surface topography of silicon nitride affects antimicrobial and osseointegrative properties of tibial implants in a murine model.

Authors:  Masahiro Ishikawa; Karen L de Mesy Bentley; Bryan J McEntire; B Sonny Bal; Edward M Schwarz; Chao Xie
Journal:  J Biomed Mater Res A       Date:  2017-09-26       Impact factor: 4.396

8.  mRNA Transcriptome Analysis of Bone in a Mouse Model of Implant-Associated Staphylococcus aureus Osteomyelitis.

Authors:  Yihuang Lin; Jianwen Su; Yutian Wang; Daorong Xu; Xianrong Zhang; Bin Yu
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

9.  A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings.

Authors:  Nicholas M Bernthal; Alexandra I Stavrakis; Fabrizio Billi; John S Cho; Thomas J Kremen; Scott I Simon; Ambrose L Cheung; Gerald A Finerman; Jay R Lieberman; John S Adams; Lloyd S Miller
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

10.  Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.

Authors:  John J Varrone; Karen L de Mesy Bentley; Sheila N Bello-Irizarry; Kohei Nishitani; Sarah Mack; Joshua G Hunter; Stephen L Kates; John L Daiss; Edward M Schwarz
Journal:  J Orthop Res       Date:  2014-07-03       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.